SpringWorks Therapeutics Inc (NASDAQ:SWTX) price on Wednesday, February 05, rose 6.77% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $41.00.
A look at the stock’s price movement, the close in the last trading session was $38.40, moving within a range at $38.52 and $41.275. The beta value (5-Year monthly) was 0.792. Turning to its 52-week performance, $53.92 and $28.21 were the 52-week high and 52-week low respectively. Overall, SWTX moved 7.36% over the past month.
SpringWorks Therapeutics Inc’s market cap currently stands at around $3.05 billion, with investors looking forward to this quarter’s earnings report slated for in March.
Analysts have a consensus estimate of 60.87M for the company’s revenue for the quarter, with a low and high estimate of 57M and 62.86M respectively. The average forecast suggests up to a 1,017.42% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 190.57M, representing a 3,398.61% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that SWTX is a Hold. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend SWTX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
SWTX’s current price about 10.85% and 7.64% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 61.17, while 7-day volatility ratio is 6.90% and 8.53% in the 30-day chart. Further, SpringWorks Therapeutics Inc (SWTX) has a beta value of 0.85, and an average true range (ATR) of 2.66. Analysts have given the company’s stock an average 52-week price target of $77, forecast between a low of $76 and high of $78. Looking at the price targets, the low is -85.37% off current price level while to achieve the yearly target high, price needs to move -90.24%. Nonetheless, investors will most likely welcome a -87.8% jump to $77 which is the analysts’ median price.
If we refocus on SpringWorks Therapeutics Inc (NASDAQ:SWTX), historical trading data shows that trading volumes averaged 1.41 over the past 10 days and 1.43 million over the past 3 months. The company’s latest data on shares outstanding shows there are 74.34 million shares.
The 11.59% of SpringWorks Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 102.77% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 13.66 million on 2025-01-15, giving us a short ratio of 8.57. The data shows that as of 2025-01-15 short interest in SpringWorks Therapeutics Inc (SWTX) stood at 2221.9999 of shares outstanding, with shares short rising to 11.69 million registered in 2024-12-13. Current price change has pushed the stock 13.48% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the SWTX stock continues to rise going into the next quarter.
